menu
    • menu

    Company profile for Nephron Pharmaceuticals Corporation

    NEW Drugs in Dev: 2
    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Sigma-Aldrich empowers scientific discovery with top-quality solutions to accelerate research, innovation, and better health worldwide.

    Virtual Booth

    Contact Supplier

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    Virtual Booth

    Contact Supplier

    TransoPharm USA works in the Sourcing and Management of Active Pharmaceutical Ingredients.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Nephron Pharmaceuticals Corporation is a privately owned manufacturer of generic inhalation solutions headquartered in Orlando, FL. Nephron specializes in blow-fill-seal (BFS) manufacturing, a technology that allows a vial of medication to be formed, filled and sealed in a continuous process without human intervention in a sterile, enclosed area.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Nephron Pharmaceuticals CorporationUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    4121 SW 34th Street Orlando, FL 32811
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nephronpharm.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nephron’s Generics Norepinephrine Receives Approval in US
    Nephron’s Generics Norepinephrine Receives Approval in US

    11 Jun 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216272

    FDA
    11 Jun 2026
    Share Share
    Nephron’s Generics Levalbuterol HCl Receives Approval in US
    Nephron’s Generics Levalbuterol HCl Receives Approval in US

    26 May 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215217

    FDA
    26 May 2026
    Share Share
    Enforcement Report - Week of April 22, 2026
    Enforcement Report - Week of April 22, 2026

    22 Apr 2026

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-22-2026-72558.pdf

    FDA
    22 Apr 2026
    Share Share
    FDA Issues Form 483 to Nephron Pharmaceuticals
    FDA Issues Form 483 to Nephron Pharmaceuticals

    22 Sep 2025

    // FDA

    https://www.fda.gov/media/188822/download

    FDA
    22 Sep 2025
    Share Share
    Sharps Receives $30 Million Purchase Order for Prefillable Copolymer Syringes
    Sharps Receives $30 Million Purchase Order for Prefillable Copolymer Syringes

    13 Jun 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/06/13/2898262/0/en/Sharps-Technology-Receives-30-Million-Purchase-Order-for-Prefillable-Copolymer-Syringes-to-be-Manufactured-at-SC-Facility.html

    GLOBENEWSWIRE
    13 Jun 2024
    Share Share
    Nephron Announces Hiring of Key Executives
    Nephron Announces Hiring of Key Executives

    24 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nephron-announces-hiring-of-key-executives-301966007.html

    PR NEWSWIRE
    24 Oct 2023
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search